Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer

Introduction. Gastric cancer (GC) represents one of the most common cancers worldwide, frequently diagnosed at advanced stages with poor prognosis, indicating on need for new diagnostic and prognostic markers. The aim of the study was to determine the expression of IL-32, proinflammatory and angioge...

Full description

Saved in:
Bibliographic Details
Main Authors: Mladen Pavlovic, Nevena Gajovic, Milena Jurisevic, Slobodanka Mitrovic, Gordana Radosavljevic, Jelena Pantic, Nebojsa Arsenijevic, Ivan Jovanovic
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/6578273
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567865435226112
author Mladen Pavlovic
Nevena Gajovic
Milena Jurisevic
Slobodanka Mitrovic
Gordana Radosavljevic
Jelena Pantic
Nebojsa Arsenijevic
Ivan Jovanovic
author_facet Mladen Pavlovic
Nevena Gajovic
Milena Jurisevic
Slobodanka Mitrovic
Gordana Radosavljevic
Jelena Pantic
Nebojsa Arsenijevic
Ivan Jovanovic
author_sort Mladen Pavlovic
collection DOAJ
description Introduction. Gastric cancer (GC) represents one of the most common cancers worldwide, frequently diagnosed at advanced stages with poor prognosis, indicating on need for new diagnostic and prognostic markers. The aim of the study was to determine the expression of IL-32, proinflammatory and angiogenic mediators, in patients with diffuse and intestinal gastric cancer and the relationship with clinicopathological aspects. Material and Methods. The tissue samples of diffuse and intestinal types of tumor of 70 patients with gastric cancer were analyzed. Expression of IL-32, VEGF, IL-17, and CD31 was measured by immunohistochemistry. Results. IL-32 expression was significantly lower in tissue samples from patients with diffuse type of gastric cancer that is also a severe and more progressive form (TNM stages III and IV, poor histological differentiation, and higher nuclear grade III). Expression of IL-17 was also decreased in patients with diffuse type of gastric cancer. Microvascular density was diminished in diffuse type of gastric cancer. Conclusions. Downregulated expression of IL-32 in tumor tissue of patients with diffuse type of gastric cancer may implicate on its role in limiting ongoing proinflammatory and proangiogenic processes. This emphasizes on unrecognized role of IL-32 in biology of diffuse type of gastric cancer.
format Article
id doaj-art-5ec39fec11474c68a2632dd21ec31711
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-5ec39fec11474c68a2632dd21ec317112025-02-03T01:00:23ZengWileyGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/65782736578273Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric CancerMladen Pavlovic0Nevena Gajovic1Milena Jurisevic2Slobodanka Mitrovic3Gordana Radosavljevic4Jelena Pantic5Nebojsa Arsenijevic6Ivan Jovanovic7Department of Surgery, Faculty of Medical Sciences, University of Kragujevac, SerbiaCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaDepartment of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, SerbiaDepartment of Pathology, Faculty of Medical Sciences, University of Kragujevac, SerbiaCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaCenter for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, SerbiaIntroduction. Gastric cancer (GC) represents one of the most common cancers worldwide, frequently diagnosed at advanced stages with poor prognosis, indicating on need for new diagnostic and prognostic markers. The aim of the study was to determine the expression of IL-32, proinflammatory and angiogenic mediators, in patients with diffuse and intestinal gastric cancer and the relationship with clinicopathological aspects. Material and Methods. The tissue samples of diffuse and intestinal types of tumor of 70 patients with gastric cancer were analyzed. Expression of IL-32, VEGF, IL-17, and CD31 was measured by immunohistochemistry. Results. IL-32 expression was significantly lower in tissue samples from patients with diffuse type of gastric cancer that is also a severe and more progressive form (TNM stages III and IV, poor histological differentiation, and higher nuclear grade III). Expression of IL-17 was also decreased in patients with diffuse type of gastric cancer. Microvascular density was diminished in diffuse type of gastric cancer. Conclusions. Downregulated expression of IL-32 in tumor tissue of patients with diffuse type of gastric cancer may implicate on its role in limiting ongoing proinflammatory and proangiogenic processes. This emphasizes on unrecognized role of IL-32 in biology of diffuse type of gastric cancer.http://dx.doi.org/10.1155/2018/6578273
spellingShingle Mladen Pavlovic
Nevena Gajovic
Milena Jurisevic
Slobodanka Mitrovic
Gordana Radosavljevic
Jelena Pantic
Nebojsa Arsenijevic
Ivan Jovanovic
Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
Gastroenterology Research and Practice
title Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
title_full Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
title_fullStr Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
title_full_unstemmed Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
title_short Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
title_sort diverse expression of il 32 in diffuse and intestinal types of gastric cancer
url http://dx.doi.org/10.1155/2018/6578273
work_keys_str_mv AT mladenpavlovic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT nevenagajovic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT milenajurisevic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT slobodankamitrovic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT gordanaradosavljevic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT jelenapantic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT nebojsaarsenijevic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer
AT ivanjovanovic diverseexpressionofil32indiffuseandintestinaltypesofgastriccancer